Home > Publications Database > Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient. > print

001     155630
005     20221128161131.0
024 7 _ |a 10.1080/10428194.2021.1889537
|2 doi
024 7 _ |a pmid:33612072
|2 pmid
024 7 _ |a 1026-8022
|2 ISSN
024 7 _ |a 1029-2403
|2 ISSN
024 7 _ |a 1042-8194
|2 ISSN
037 _ _ |a DZNE-2021-00798
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Bittner, Aitomi
|0 0000-0001-6434-0950
|b 0
|e Corresponding author
245 _ _ |a Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient.
260 _ _ |a London [u.a.]
|c 2021
|b Taylor & Francis Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1630483548_17166
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|x 0
|f POF IV
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Programmed Cell Death 1 Receptor
|2 NLM Chemicals
650 _ 2 |a Epstein-Barr Virus Infections: complications
|2 MeSH
650 _ 2 |a Herpesvirus 4, Human
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Liver Transplantation
|2 MeSH
650 _ 2 |a Lymphoproliferative Disorders: diagnosis
|2 MeSH
650 _ 2 |a Lymphoproliferative Disorders: etiology
|2 MeSH
650 _ 2 |a Programmed Cell Death 1 Receptor: antagonists & inhibitors
|2 MeSH
650 _ 2 |a Viral Load
|2 MeSH
700 1 _ |a Radke, Josefine
|b 1
700 1 _ |a Eurich, Dennis
|b 2
700 1 _ |a Wiener, Edzard
|b 3
700 1 _ |a Denker, Sophy
|b 4
700 1 _ |a Anagnostopoulos, Ioannis
|b 5
700 1 _ |a Na, Il-Kang
|b 6
700 1 _ |a Heppner, Frank L
|0 P:(DE-2719)2812386
|b 7
|u dzne
700 1 _ |a Bullinger, Lars
|b 8
700 1 _ |a Schmitt, Clemens A
|b 9
773 _ _ |a 10.1080/10428194.2021.1889537
|g Vol. 62, no. 8, p. 2026 - 2029
|0 PERI:(DE-600)2030637-4
|n 8
|p 2026 - 2029
|t Leukemia and lymphoma
|v 62
|y 2021
|x 1029-2403
909 C O |o oai:pub.dzne.de:155630
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2812386
913 0 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2021-02-02
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LEUKEMIA LYMPHOMA : 2019
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-02-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-02
920 1 _ |0 I:(DE-2719)1810007
|k AG Heppner
|l Neuroimmunology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1810007
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21